Arch Capital's stock has been volatile, impacted by California wildfire losses, but core business performance remains strong.

ICICI Venture Capital and Leverage India Fund (jointly sponsored by IL&FS and Punjab National Bank) are among the few other financial investors in mid-sized drugmaker Arch Pharmalabs who are ...

Concurrently, AM Best has revised the outlook to positive from stable and affirmed the Long-Term ICRs of “a-” (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of Arch Capital ...

Arch Capital Group Ltd (NASDAQ:ACGL) is set to release its Q4 2024 earnings on Feb 11, 2025.The consensus estimate for Q4 2024 revenue is $3.91 billion, and the earnings are expected to come in at ...

In its fourth quarter 2024 investor letter, Baron Asset Fund emphasized stocks such as Arch Capital Group Ltd. (NASDAQ:ACGL). Arch Capital Group Ltd. (NASDAQ:ACGL) offers insurance, reinsurance ...